CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Revance Therapeutics, Inc. vs. Medy-Tox, Inc.

Explore the PTAB proceeding IPR2021-01203 filed by Revance Therapeutics, Inc. on 2021-07-01. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2021-01203

Filing Date

2021-07-01

Accorded Filing Date

2021-07-01

Institution Decision Date

2022-01-19

Last Modified Date

2022-09-17

Proceeding Type

IPR

Termination Date

2022-01-19

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 14567289
Respondent Patent Number 9480731
Legal Expiration Date
2035-01-15 Active (8.2 yrs remaining)
Patent Term Adjustment (PTA) +35 Days Awarded
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Hyun Ho Jung et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Institution Denied 2022-01-19
Institution Decision: Deny
35 USC 314, 37 CFR 42.100, 35 USC 311

Address and Attorney/Agent Information

29 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name ALLERGAN, INC.
Customer Number 51957
Address 2525 DUPONT DRIVE, IRVINE, CA, 92612, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
36373 Allan Brookes +1 508-733-3757
44075 Portia Chen +1 847-937-8272
44554 Matthew Brady +1 714-246-4788
46652 Stephen D'Amico +1 224-440-7242
46789 Mark Hyman +1 847-937-8941
47413 Eric Baude +1 847-938-8389
47717 Renee Kosslak +1 650-454-2338
48591 Tara Seshadri +1 508-688-8058

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 2 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 2
USPTO PTAB Trial 2021-07-01
IPR2021-01204

Revance Therapeutics, Inc. v. Medy-Tox, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2019-09-04
PGR2019-00062

Galderma S.A. et al. v. Medy-Tox, Inc. et al.

U.S. Continuation Sibling (10143728)
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

81
13

Denying Petitioner Request on Rehearing of Decision Denying Institution 37 C.F.R. ยง 42.71(d) Paper

2022-08-04 FILING PARTY: BOARD
12

Petitioner's Request for Rehearing MOTION

2022-02-18 FILING PARTY: PETITIONER
11

Institution Decision: Deny DECISION

2022-01-19 FILING PARTY: BOARD
3001

Exhibit 3001 Exhibit

2022-01-19 FILING PARTY: BOARD
10

Patent Owner's Sur-Reply to Petitioner's Reply to Patent Owner's Preliminary Response Paper

2021-12-06 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc